HomeNews

News

  • Novo Nordisk to focus on Parkinson’s & Diabetes stem cell-based therapies

    • May 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • EIP pharma secures $20.5m funding for Alzheimer’s drug trial

    • May 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Teva Announces Publication of Ph III Data of Fremanezumab for the Preventive Treatment of Episodic Migraine

    • May 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Focal cortical dysplasia in Epilepsy associated with dysregulation of gene NEUROG2

    • May 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Molecule shows potential to stop Alzheimer’s disease progression

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Bellerophon to Present Positive Results from Phase 2 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with COPD at ATS Conference

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Progression from CIS to MS to be predicted by Peripheral blood cells, research finds

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NTCELL for Parkinson’s disease shows promising results on efficacy and safety in Ph II trials

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Lilly’s Galcanezumab Meets Primary Endpoint in Ph 3 Study for Episodic Cluster Headache

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Positive Ph 1 data for Xenon’s Anti-Epileptic drug presented at Eilat Conference

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more